{"id":224633,"date":"2025-12-10T00:21:08","date_gmt":"2025-12-10T00:21:08","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/224633\/"},"modified":"2025-12-10T00:21:08","modified_gmt":"2025-12-10T00:21:08","slug":"blood-pressure-medication-bottles-recalled-due-to-cross-contamination","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/224633\/","title":{"rendered":"Blood pressure medication bottles recalled due to cross-contamination"},"content":{"rendered":"<p>Glenmark Pharmaceuticals has <a class=\"Link\" href=\"https:\/\/www.scrippsnews.com\/life\/recalls\" rel=\"nofollow noopener\" target=\"_blank\">recalled<\/a> over 11,000 bottles of Ziac tablets, a common blood pressure medication, after the drug may have been cross-contaminated with a cholesterol medication called ezetimibe.<\/p>\n<p>The FDA says the contamination is not likely to cause serious health problems for patients who may have taken the affected medication.<\/p>\n<p>The recalled tablets range from 2.5 milligrams to 6.25 milligrams. The recalled lots have expiration dates of Nov. 2025 and May 2026.<\/p>\n<p><b>RELATED STORY | <\/b><a class=\"Link\" href=\"https:\/\/www.scrippsnews.com\/life\/recalls\/half-a-million-bottles-of-blood-pressure-drug-recalled-for-high-carcinogen-levels\" rel=\"nofollow noopener\" target=\"_blank\"><b>Half a million bottles of blood pressure drug recalled for high carcinogen levels<\/b><\/a><\/p>\n<p>Patients should check their medication lot numbers and contact their pharmacist if their medication is affected by the recall.<\/p>\n<p>This story was reported on-air by a journalist and has been converted to this platform with the assistance of AI. Our editorial team verifies all reporting on all platforms for fairness and accuracy.<\/p>\n","protected":false},"excerpt":{"rendered":"Glenmark Pharmaceuticals has recalled over 11,000 bottles of Ziac tablets, a common blood pressure medication, after the drug&hellip;\n","protected":false},"author":2,"featured_media":224634,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[18,135,19,17,462],"class_list":{"0":"post-224633","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-eire","9":"tag-health","10":"tag-ie","11":"tag-ireland","12":"tag-medication"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115692416750481282","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/224633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=224633"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/224633\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/224634"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=224633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=224633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=224633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}